MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) announced today that its new Genius™ Digital Diagnostics System is now CE marked in Europe. Genius Digital Diagnostics is the first ...

Through a Combination of Advanced Imaging and Novel Artificial Intelligence, Latest Diagnostic System for Cervical Cancer Screening Can Help More Accurately Detect Disease, Improve Workflow and ...

Medical technology firm Hologic has been granted clearance from the FDA to market its Genius Digital Diagnostics System, powered by the company's Genius Cervical AI algorithm. The digital cytology ...

For the second time just this week, an artificial intelligence-powered tool aimed at improving cervical cancer screening is taking center stage. This time around, Hologic is the star of the show. Its ...

During Cervical Cancer Awareness Week, NewsMedical spoke with Tim Simpson, General Manager for the UK and Ireland at Hologic, a leader in women's health technology. Hologic is renowned for pioneering ...

Hologic (NASDAQ:HOLX) has received approval from the U.S. Food and Drug Administration (FDA) approval for its new digital cytology system, making it the first FDA-cleared digital cytology platform.

“Hologic has been at the forefront of cervical cancer screening for decades, and the additional indication of the Aptima HPV Assay reflects our ongoing commitment to advancing women’s health through ...

To address the issue, HealthBay Vitalia, Jumeirah has unveiled a new state-of-the-art Breast Clinic. The facility offers women across the UAE access to the revolutionary Hologic 3Dimensions ...

Hologic’s HOLX Genius Digital Diagnostics System has achieved expanded CE marking in the European Union. The development signals a promising step in the company’s innovation pipeline focused on ...